摘要 |
A composition includes particles including at least about 95 wt% of amphotericin B, wherein the particles have a mass median diameter ranging from about 1.1 µm to about 1.9 µm. Another composition also includes particles including at least about 95 wt% of amphotericin B, wherein at least about 80 wt% of the particles have a geometric diameter ranging from about 1.1 µm to about 1.9 gm. Yet another composition includes particles including amphotericin B, wherein the particles have a mass median diameter less than about 1.9 µm, and wherein the amphotericin B has a crystallinity level of at least about 20%. Unit dosage forms, delivery systems, and methods may involve similar compositions. |
申请人 |
NEKTAR THERAPEUTICS;DUDDU, SARMA;PALAKODATY, SRINIVAS;LECHUGA-BALLESTEROS, DAVID;MILLER, DANFORTH;KUGLER, ALAN, R.;FRANTZ, CHRISTOPHER;TAN, TRIXIE;MALCOLMSON, RICHARD;WASHCO, KEITH;SWEENEY, THERESA;TARARA, THOMAS, E.;DWIVEDI, SARVAJNA;ELDON, MICHAEL, A. |
发明人 |
DUDDU, SARMA;PALAKODATY, SRINIVAS;LECHUGA-BALLESTEROS, DAVID;MILLER, DANFORTH;KUGLER, ALAN, R.;FRANTZ, CHRISTOPHER;TAN, TRIXIE;MALCOLMSON, RICHARD;WASHCO, KEITH;SWEENEY, THERESA;TARARA, THOMAS, E.;DWIVEDI, SARVAJNA;ELDON, MICHAEL, A. |